<b>Conclusions</b>: These findings create a connection between the ubiquitin-proteasome system and the unchecked growth observed in GBM, identifying RNF182 as a new marker associated with GBM proliferation and an additional target for GBM treatment. Here, RNF182 is linked to glioblastoma.